Newsfeeds Archive - Page 16 of 696

1 minute read

Alpine Immune Sciences To Present Initial Clinical Data On Povetacicept In Autoimmune Glomerulonephritis In A Late Breaker Poster Session At American Society Of Nephrology Kidney Week 2023

October 13, 9:08 AM

-- The Company will host an investor event following the presentation after the close of market on Thursday, November 2nd -- Alpine Immune Sciences, Inc. (NASDAQ:ALPN), a leading clinical-stage

ALPN

2 minute read

Lexaria Enters New Global Exclusive Collaboration And License Agreement With SulfoSyn; Global Exclusivity For All Non-Pharmaceutical Applications Of DehydraTECH-Sulforaphane Has Been Awarded

By Happy Mohamed

October 13, 9:07 AM

Global exclusivity for all non-pharmaceutical applications of DehydraTECH-sulforaphane has been awarded Minimum ongoing payments, royalties and manufacturing revenues part of the agreement KELOWNA, BC / ACCESSWIRE /

LEXX

2 minute read

EuroDry Ltd. Announces Delivery Of M/V YANNIS PITTAS, An Eco Ultramax Drybulk Carrier; The Vessel Is Employed Under A Time Charter Contract Until December 2023 At $12,500 Per Day

By Happy Mohamed

October 13, 9:04 AM

EuroDry Ltd. (NASDAQ:EDRY, the ", Company", or ", EuroDry", )))), an owner and operator of drybulk vessels and provider of seaborne transportation for drybulk cargoes, announced today that it took

EDRY

2 minute read

ADDvantage Technologies’ Service Subsidiary Executes Agreements With Leading Optical Communications OEMs

By Happy Mohamed

October 13, 9:02 AM

ADDvantage Technologies Group, Inc. (NASDAQ:AEY) ("ADDvantage Technologies" or the "Company") today announced that wholly owned subsidiary, Fulton Technologies ("Fulton") Inc., has executed

AEY

2 minute read

‘Microsoft Closes Acquisition Of Activision Blizzard After Lengthy Regulatory Review’ – CNBC

By Happy Mohamed

October 13, 8:39 AM

https://www.cnbc.com/2023/10/13/microsoft-closes-activision-blizzard-deal-after-regulatory-review.html Nineteen months after agreeing to the company's largest purchase ever, Microsoft has closed its acquisition of Activision Blizzard. The deal was put through a hefty regulatory review and has finally gained a favorable ruling from a U.S. district judge.

ATVI

2 minute read

Nuwellis Announces Pricing Of $2.25M Public Offering Of Series J Convertible Redeemable Preferred Stock And Warrants

By Happy Mohamed

October 13, 8:33 AM

Nuwellis, Inc. (NASDAQ:NUWE) ("Nuwellis" or the "Company"), a commercial-stage company focused on transforming the lives of people with fluid overload, today announced the pricing of a public offering

NUWE

3 minute read

DSS Inc. Issues Letter To Shareholders Providing An Update On Progress So Far This Year And Expectations Going Into The End Of The Year

By Happy Mohamed

October 12, 8:28 AM

DSS, Inc. (NYSE:DSS), a multinational company operating nine (9) diversified business lines developed through strategic acquisitions to build shareholder value through periodic spinoffs to its shareholders, announced today that it has issued a Letter to Shareholders. Dear Valued Shareholders,

DSS

2 minute read

Presto Announces New Interim CFO, Nathan Cook, Joining Effective Today; Increased Ownership Commitment By Major Existing Shareholder Cleveland Avenue

By Happy Mohamed

October 10, 4:49 PM

Increased Ownership from a Major Existing Shareholder and Lock-up Commitment from Certain Existing Shareholders Presto announced today that one of its existing major shareholders, Cleveland Avenue, has agreed to

PRST

3 minute read

Akero Therapeutics To Present Results From Phase 2b SYMMETRY Study Investigating Efruxifermin In Patients With Compensated Cirrhosis Due To NASH

By Happy Mohamed

October 9, 4:09 PM

Akero Therapeutics, Inc. (NASDAQ:AKRO), a clinical-stage company developing transformational treatments for patients with serious metabolic disease marked by high unmet medical need, will hold an investor conference on

AKRO

1 minute read

ImmuCell Announces Preliminary, Unaudited Sales Results For Q3 2023; Sees Q3 Revenue $5.4M Vs 4.8M YoY

By Happy Mohamed

October 5, 4:11 PM

ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), a growing animal health company that develops, manufactures and markets scientifically proven and practical

ICCC